This article attempts to present some highlights from the rich economic literature pertaining to interventional cardiology and transcatheter aortic valve implantation (TAVI). There are currently more questions than answers, not surprisingly given the pace of technological change in interventional cardiology. For clinicians who work in a strictly regulated environment and have limited control over their use of medical technologies, this article will hopefully shed some light on the motives for policy decisions. For clinicians who make decisions on the resources used to treat their patients, it aims to provide the means of looking for evidence that will allow for informed decisions from both clinical and economic perspectives.
Matthias Brunn - Research Fellow, Paris Health Economics and Health Services Research Unit (URC Eco), Paris, France
Isabelle Durand-Zaleski - Director, Paris Health Economics and Health Services Research Unit (URC Eco) and Department of Public Health at Henri Mondor Hospital, Paris, France
